"AbbVie's Longtime CEO Rick Gonzalez Steps Down, Successor Named"

TL;DR Summary
AbbVie CEO Richard Gonzalez, who has led the company since its spinoff from Abbott Laboratories in 2013, will step down in July, to be replaced by COO Robert Michael. Gonzalez's departure comes as AbbVie faces competition for its top-selling drug, Humira, from cheaper biosimilars. Despite criticism over AbbVie's handling of Humira and its patents, Gonzalez's legacy is likely to be remembered fondly by investors for his leadership during the drug's challenges.
- AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira STAT
- AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez CNBC
- AbbVie CEO telegraphs retirement and prepares to pass baton to long-time deputy Robert Michael FiercePharma
- AbbVie Names New CEO. The Stock’s Not Moving. Barron's
- Rick Gonzalez, longtime AbbVie CEO, to step down in July Yahoo Finance
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
1 min
vs 1 min read
Condensed
61%
183 → 71 words
Want the full story? Read the original article
Read on STAT